期刊文献+

GH-IGF-1轴基因与特发性矮小相关性研究进展 被引量:9

Progress in Association between GH-IGF Axis Genes and Idiopathic Short Stature
下载PDF
导出
摘要 特发性矮小(idiopathic short stature,ISS)是一组病因未明的导致身材矮小疾病的总称,排除了生长激素缺乏症(growth hormone deficiency,GHD),小于胎龄儿(small for gestational age,SGA)、系统性疾病、其他内分泌疾病、营养性疾病、染色体异常、骨骼发育不良、心理情感障碍等导致的矮身材。生长激素-胰岛素样生长因子-1轴(growth hormone-insulin-like growth factor-1axis,GH-IGF-1轴)是调节儿童生长发育中最重要的神经内分泌轴,GH-IGF-1轴中GHR基因、IGFs基因、STAT5b基因、软骨生长板相关基因等的异常表达均可能与特发性矮小发病机制紧密相关。 Idiopathic short stature(ISS) refers to a group of conditions of short stature of un known etiology,which are not associated with growth hormone deficiency, small for gestational age, systemic diseases, other endocrine diseases, nutritional diseases, chromosomal abnormalities, bone dysplasia and mental and emotional disorders. Growth hormone insulin like growth factor (GH-IGF) axis is the most important neuroendocrine axis that regulates the growth and develop ment of children.In GH-IGF axis,abnormal expression of GHR,IGFs,STATSb and growth plate cartilage related genes may be closely involved in the pathogenesis of ISS.
作者 帅霞 杨玉 SHUAI-Xia;YANG-Yu(Department of Endocrine Genetic Metabolism,Jiangxi Provincial Children's Hospital,Nanchang 330006,China)
出处 《南昌大学学报(医学版)》 CAS 2018年第4期90-94,共5页 Journal of Nanchang University:Medical Sciences
关键词 生长激素-胰岛素样生长因子-1 基因变异 特发性矮小 growth hormone insulin like growth factor genetic variation lidiopathic short stature
  • 相关文献

参考文献2

二级参考文献17

  • 1Cohen P, Rogol AD, Deal CL, Saenger P, Reiter EO, Ross JL, et al. Consensus statement on the diognosis and treatment of children with idiopathic short stature: a summary of the growth hormone research society, the lawson wilkinspediatric endocrine society, and the European society for paediatric endocrinology workshop[J]. J Clin Endocrinol Metab, 2005, 93(11): 4210-4217. 被引量:1
  • 2Brase JC, Wuttig D, Kuner R, Sultmann H. Serum microRNAs as non-invasive biomarkers for cancer[J]. Molecular Cancer, 2010,9:306. 被引量:1
  • 3Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yerushalmi N, et al. Serum microRNAs are promising novel biomarkers[J]. PLoS One, 2008, 3(9): 3148. 被引量:1
  • 4Gui J, Tian Y, Wen X, Zhang W, Zhang P, Gao J, et al. Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies[J]. Clin Sei(Lond), 2011, 120(5): 183-193. 被引量:1
  • 5Ma Y, Wang X, Jin H. Methylated DNA and microRNA in Body Fluids as Biomarkers for Cancer Detection[J]. Int J Mol Sei, 2013, 4(5): 10307-10331. 被引量:1
  • 6Ji X, Takahashi R, Hiura Y, Hirokawa G, Fukushima Y, Iwai N. Plasma miR-208 as a biomarker of myocardial injury[J]. Clin Chem, 2009, 55(11): 1944-1949. 被引量:1
  • 7Wang K, Zhang S, Marzolf B, Troiseh P, Brightman A, Hu Z, et al. Circulating mieroRNAs, potential biomarkers for drug-induced liver injury[J]. Proe Natl Acad Sei USA, 2009, 106(11): 4402- 4407. 被引量:1
  • 8Vasilescu C, Rossi S, Shimizu M, Tudor S, Veronese A, Ferraein M, et al. MieroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis[J]. PLoS One, 2009, 4(10): e7405. 被引量:1
  • 9Kirschner MB, Edelman JJ, Kao SC, Vallely MP, van ZandwijkN, Reid G. The impact of hemolysis on cell-Free microRNA biomarkers[J]. Front Genet, 2013, 4: 94. 被引量:1
  • 10Djuranovic S, Nahvi A, Green R. A parsimonious model for gene regulation by miRNAs[J]. Science, 2011,331(6017): 550-553. 被引量:1

共引文献2

同被引文献108

引证文献9

二级引证文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部